Literature DB >> 16517429

Prognosis of cough variant asthma: a retrospective analysis.

Hisako Matsumoto1, Akio Niimi, Masaya Takemura, Tetsuya Ueda, Rollin Tabuena, Masafumi Yamaguchi, Hirofumi Matsuoka, Toyohiro Hirai, Shigeo Muro, Yutaka Ito, Tadashi Mio, Kazuo Chin, Hideki Nishiyama, Michiaki Mishima.   

Abstract

Patients with cough variant asthma, a common cause of chronic cough, may develop wheezing. We examined the determinants of this phenomenon and achievement of remission in 42 patients. During 4 years after diagnosis, wheezing developed in 13 of the patients. Early inhaled corticosteroid treatment was inhibitory against the development of wheezing by univariate analysis and by multivariate analysis with an odds ratio of 0.12 (95% confidence interval, 0.02 to 0.87, p = 0.037). Remission was achieved in 7 patients, who were younger than those without remission by univariate analysis (p = 0.048). Early treatment with inhaled corticosteroid may prevent the progression of cough variant asthma to classic asthma.

Entities:  

Mesh:

Year:  2006        PMID: 16517429     DOI: 10.1080/02770900500498477

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  17 in total

1.  Chinese National Guidelines on Diagnosis and Management of Cough: consensus and controversy.

Authors:  Kefang Lai
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 2.  Cough due to asthma and nonasthmatic eosinophilic bronchitis.

Authors:  Christopher E Brightling
Journal:  Lung       Date:  2009-08-08       Impact factor: 2.584

3.  Retrospective Study of the Effects of Post-nasal Drip Symptoms on Cough Duration.

Authors:  Takeo Nakajima; Tatsuya Nagano; Yoshihiro Nishimura
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

4.  Computer-aided intelligent system for diagnosing pediatric asthma.

Authors:  Maryam Zolnoori; Mohammad Hossein Fazel Zarandi; Mostafa Moin; Hassan Heidarnezhad; Anoshirvan Kazemnejad
Journal:  J Med Syst       Date:  2010-07-10       Impact factor: 4.460

5.  [Comparison of functional parameters of small airways between patients with typical asthma and cough-variant asthma].

Authors:  Shu-Yu Chen; Ze-Kui Fang; Si Fang; Qi-Xiao Shen; Xi He; Cui-Lan Wang; Hua-Peng Yu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-03-20

6.  An Open-Label, Multi-Institutional, Randomized Study to Evaluate the Additive Effect of a Leukotriene Receptor Antagonist on Cough Score in Patients with Cough-Variant Asthma Being Treated with Inhaled Corticosteroids.

Authors:  Nanako Miwa; Tatsuya Nagano; Hisashi Ohnishi; Teruaki Nishiuma; Kazuhiro Takenaka; Tomohiko Shirotani; Takeo Nakajima; Ryota Dokuni; Yoshitaka Kawa; Kazuyuki Kobayashi; Yasuhiro Funada; Yoshikazu Kotani; Yoshihiro Nishimura
Journal:  Kobe J Med Sci       Date:  2018-12-04

7.  Retrospective Analysis of the Starting Dose of Combined ICS/LABA for Cough-variant Asthma and Cough-predominant Asthma.

Authors:  Takeo Nakajima; Tatsuya Nagano; Yoshihiro Nishimura
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

8.  A History of Recurrent Episodes of Prolonged Cough as a Predictive Value for Determining Cough Variant Asthma in a Primary Care Setting.

Authors:  Masaaki Mikami; Katsuyuki Tomita; Akira Yamasaki
Journal:  Yonago Acta Med       Date:  2021-11-29       Impact factor: 1.641

9.  Unusual asthma syndromes and their management.

Authors:  Jaymin B Morjaria; Jack A Kastelik
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

10.  MicroRNA-223 inhibits deposition of the extracellular matrix by airway smooth muscle cells through targeting IGF-1R in the PI3K/Akt pathway.

Authors:  Dongdong Liu; Jing Pan; Deyu Zhao; Feng Liu
Journal:  Am J Transl Res       Date:  2018-03-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.